Sale!

Petmedin 2.5mg (Pimobendan) Tablet for Dogs 30 Tablets

Original price was: ₹1,172.00.Current price is: ₹1,078.00.

Availability: In Stock

30 Tablets

  • Delivery Information: 2-3 working days in Delhi NCR , all other cities within 4-5 working days.

Description

 

Petmedin 2.5mg (Pimobendan) Tablet for Dogs

Petmedin 2.5mg (Pimobendan) Tablet for Dogs is a trusted veterinary cardiac medication formulated to manage congestive heart failure (CHF) in dogs. Containing Pimobendan 2.5mg, this medication acts as an inodilator, improving the heart’s pumping strength while dilating blood vessels to enhance blood circulation and reduce cardiac workload.

Petmedin 2.5mg is commonly prescribed for dogs diagnosed with dilated cardiomyopathy (DCM) and mitral valve disease (MVD). By increasing cardiac output and lowering pressure on the heart, it helps reduce symptoms such as coughing, fatigue, breathing difficulty, and exercise intolerance.

Regular administration as directed by a veterinarian supports improved quality of life, better stamina, and enhanced overall heart function. The tablet form allows precise dosing and convenient daily administration.

Key Benefits

  • Contains Pimobendan 2.5mg
  • Effective management of congestive heart failure in dogs
  • Improves heart contractility and blood flow
  • Reduces strain on the heart
  • Supports dogs with DCM and mitral valve disease
  • Easy-to-administer veterinary tablet

Indications

  • Congestive heart failure (CHF)
  • Dilated cardiomyopathy (DCM)
  • Mitral valve insufficiency
  • Reduced cardiac output in dogs

Directions for Use

Administer strictly as prescribed by a licensed veterinarian. Usually given on an empty stomach or as advised. Do not change dosage without professional consultation.

Storage

Store in a cool, dry place away from moisture and direct sunlight. Keep out of reach of children and pets.

Reviews

There are no reviews yet.

Be the first to review “Petmedin 2.5mg (Pimobendan) Tablet for Dogs 30 Tablets”

Your email address will not be published. Required fields are marked *